Anzeige
Mehr »
Sonntag, 29.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CS0U | ISIN: KYG0405D1051 | Ticker-Symbol: 77D
Frankfurt
27.06.25 | 08:02
5,900 Euro
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
ASIEN
1-Jahres-Chart
ANGELALIGN TECHNOLOGY INC Chart 1 Jahr
5-Tage-Chart
ANGELALIGN TECHNOLOGY INC 5-Tage-Chart

Aktuelle News zur ANGELALIGN TECHNOLOGY Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoANGELALIGN (06699): NEXT DAY DISCLOSURE RETURN-
DiANGELALIGN (06699): GRANT OF RESTRICTED SHARE UNITS UNDER THE POST-IPO RSU SCHEME AND GRANT OF OPTIONS UNDER THE POST-IPO SHARE OPTION SCHEME-
DiANGELALIGN (06699): PARTIALLY-EXEMPT CONTINUING CONNECTED TRANSACTIONS - ENTERING INTO PRODUCT PURCHASE COOPERATION FRAMEWORK AGREEMENT1
ANGELALIGN TECHNOLOGY Aktie jetzt für 0€ handeln
DiANGELALIGN (06699): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS1
DiANGELALIGN (06699): CHANGES IN COMPOSITION OF THE NOMINATION COMMITTEE1
DiANGELALIGN (06699): TERMS OF REFERENCE OF THE NOMINATION COMMITTEE-
23.05.ANGELALIGN (06699): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON MAY 23, 2025-
15.05.ANGELALIGN (06699): (1) RESIGNATION OF SENIOR VICE PRESIDENT, BOARD SECRETARY, COMPANY SECRETARY AND AUTHORISED REPRESENTATIVE; AND (2) APPOINTMENT OF ...-
29.04.ANGELALIGN (06699): SUPPLEMENTAL ANNOUNCEMENT CONTINUING CONNECTED TRANSACTIONS PURSUANT TO RULE 14A.60 OF THE LISTING RULES1
22.04.ANGELALIGN (06699): 2024 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT3
22.04.ANGELALIGN (06699): NOTIFICATION LETTER TO NON-REGISTERED HOLDER AND REQUEST FORM-
22.04.ANGELALIGN (06699): FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING-
22.04.ANGELALIGN (06699): NOTICE OF ANNUAL GENERAL MEETING1
22.04.ANGELALIGN (06699): (1) PROPOSED GRANT OF ISSUE MANDATE; (2) PROPOSED GRANT OF REPURCHASE MANDATE; (3) PROPOSED RE-ELECTION OF RETIRING DIRECTORS; (4) ...-
22.04.ANGELALIGN (06699): 2024 ANNUAL REPORT-
22.04.ANGELALIGN (06699): CONTINUING CONNECTED TRANSACTIONS PURSUANT TO RULE 14A.60 OF THE LISTING RULES1
21.03.ANGELALIGN (06699): GRANT OF RESTRICTED SHARE UNITS UNDER THE POST-IPO RSU SCHEME; AND CLARIFICATION IN RELATION TO THE ANNUAL RESULTS ANNOUNCEMENT FOR ...-
20.03.ANGELALIGN (06699): (REVISED) ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 20241
20.03.ANGELALIGN (06699): SPECIAL FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2024-
20.03.ANGELALIGN (06699): ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024-
Weiter >>
26 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1